Gerald Atkins

Research Interests

Ageing, Frailty and Mobility Musculoskeletal Health Surgical and Health Systems Innovation Cell Biology Cell Development, Proliferation and Death Cell Metabolism Cellular Immunology Cellular Interactions Infectious Diseases Medical Bacteriology Medical Microbiology Nanofabrication, Growth and Self Assembly Orthopaedics Pathology Rheumatology and Arthritis

Prof Gerald Atkins

Professor

School of Medicine

College of Health

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Professor Gerald Atkins, PhD, FIORProfessor of Orthopaedic Research, Scientific Director of COTR, Head, Biomedical Orthopaedic Research Group Professor Gerald Atkins' research focuses on human musculoskeletal biology, metabolism and disease, in particular those related to orthopaedics and trauma. He has previously held NHMRC RD Wright and Senior Research Fellow fellowships. He was a founding Scientific Director of the Centre for Orthopaedic and Trauma Research (COTR) and oversaw the integration of COTR research groups into the new Adelaide Health and Medical Sciences building, a central pillar in Adelaide's new Health and Medical Research Precinct. As Head of the Biomedical Orthopaedic Research Group within COTR, he runs an integrated research programme into human bone biology, underpinning translational research into musculoskeletal disease. He has an ongoing interest in bone tumour biology, including osteosarcoma and Giant Cell Tumour of bone. His group has a particular interest in the pathobiology of musculoskeletal infections, such as periprosthetic joint infection (PJI), fracture-related infection and diabetic foot infection, as well as aseptic loosening of implants and fracture repair. He has published more than 200 papers related to bone pathophysiology, which collectively have been cited more than 12,000 times (Google Scholar H-index 60). His research has attracted more than $14-million in competitive research funding. Prof. Atkins has served on the committee of the Australian New Zealand Orthopaedic Research Society (ANZORS) as representative to the International Combined Orthopaedic Research Societies (ICORS) and is a previous Councillor and Honorary Secretary to the Australian New Zealand Bone and Mineral Society (ANZBMS).

I am a Professor of Orthopaedic Research within the Centre for Orthopaedic and Trauma Research (COTR). My immediate team is the Biomedical Orthopaedic Research Group based in the Adelaide Health and Medical Sciences (AHMS) building. Following my PhD based on viral infection of haemopoietic cells, I transited into the cell biology of bone remodelling and pathobiology of its associated diseases and disorders. My group has a strong focus on the roles of osteocytes in health and disease, and translational research into orthopaedic disorders, working closely with academic orthopaedic and trauma surgeons and other clinicians at the Royal Adelaide Hospital and other metropolitan hospitals. Our current projects concern osteomyelitis (bone infection) particularly that associated with prosthetic joint infection (PJI). We use a combination of state-of-the-art molecular tools, cell biology, tissue culture, microbiology, imaging, study of patient-derived tissues and clinical cohort studies in our research.

Current projects are available in most areas of interest for 3rd Year undergraduate, Honours, Masters, M.Phil. and PhD, including for both science and medicine graduates. 
 

Date Position Institution name
2015 - ongoing Professor of Orthopaedic Research University of Adelaide

Date Institution name Country Title
1998 University of Adelaide Australia PhD

Date Title Institution name Country
— Fellow of International Orthopaedic Research (FIOR) ICORS International College of Fellows -

Year Citation
2025 Ramasamy, B., Sharma, D. K., Callary, S. A., Ramadass, B., Solomon, L. B., & Atkins, G. J. (2025). Role of gut microbiota disruption in prosthetic joint infection: a scoping review. The Lancet Microbe, 6(11), 101193-1-101193-10.
DOI
2024 Bhanushali, A., Tran, L., Nairne-Nagy, J., Bereza, S., Callary, S. A., Atkins, G., . . . Solomon, L. B. (2024). Patient-Related Predictors of Treatment Failure after Two-Stage Total Hip Arthroplasty Revision for Periprosthetic Joint Infection: A Systematic Review and Meta-Analysis. Journal of Arthroplasty, 39(9), 2395-2402.e14.
DOI Scopus10 WoS8 Europe PMC5
2024 Gunn, N. J., Kidd, S. P., Solomon, L. B., Yang, D., Roscioli, E., & Atkins, G. J. (2024). Staphylococcus aureus persistence in osteocytes: weathering the storm of antibiotics and autophagy/xenophagy. Frontiers in Cellular and Infection Microbiology, 14, 1403289-1-1403289-13.
DOI Scopus5 WoS5 Europe PMC2
2024 Sun, Q., Huynh, K., Muratovic, D., Gunn, N. J., Zelmer, A. R., Solomon, L. B., . . . Yang, D. (2024). Rapid bacterial evaluation beyond the colony forming unit in osteomyelitis. eLife, 13, RP93698-1-RP93698-11.
DOI WoS1
2024 Zelmer, A. R., Yang, D., Gunn, N. J., Solomon, L. B., Nelson, R., Kidd, S. P., . . . Atkins, G. J. (2024). Osteomyelitis-relevant antibiotics at clinical concentrations show limited effectivity against acute and chronic intracellular S. aureus infections in osteocytes. Antimicrobial Agents and Chemotherapy, 68(10), 0080824-1-0080824-14.
DOI Scopus11 WoS10 Europe PMC6
2024 Sharma, D. K., Ramadass, B., Callary, S. A., Meade, A., Dash, R., Clothier, R., . . . Ramasamy, B. (2024). The effect of prebiotic fibre on the gut microbiome and surgical outcomes in patients with prosthetic joint infection (PENGUIN) - study protocol for a randomised, double-blind, placebo-controlled trial (ACTRN12623001273673).. Nutrition Journal, 23(1), 132-1-132-9.
DOI Scopus1 Europe PMC1
2024 Muratovic, D., Atkins, G. J., & Findlay, D. M. (2024). Is RANKL a potential molecular target in osteoarthritis?. Osteoarthritis and Cartilage, 32(5), 493-500.
DOI Scopus12 WoS11 Europe PMC9
2023 Hickok, N. J., Li, B., Oral, E., Zaat, S. A. J., Armbruster, D. A., Atkins, G. J., . . . Zinkernagel, A. S. (2023). The 2023 Orthopaedic Research Society's International Consensus Meeting on Musculoskeletal Infection: Summary from the In Vitro Section.. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 42(3), 512-517.
DOI Scopus15 WoS14 Europe PMC14
2023 Sung, J., Barratt, K. R., Pederson, S. M., Chenu, C., Reichert, I., Atkins, G. J., . . . Smitham, P. J. (2023). Unbiased gene expression analysis of the delayed fracture healing observed in Zucker diabetic fatty rats.. Bone & Joint Research, 12(10), 657-666.
DOI Scopus4 WoS4 Europe PMC4
2023 Zelmer, A. R., Starczak, Y., Solomon, L. B., Richter, K., Yang, D., & Atkins, G. J. (2023). Saos-2 cells cultured under hypoxia rapidly differentiate to an osteocyte-like stage and support intracellular infection by Staphylococcus aureus.. Physiol Rep, 11(21), e15851-1-e15851-12.
DOI Scopus3 WoS3 Europe PMC4
2023 Schwarz, E. M., Archer, N. K., Atkins, G. J., Bentley, K. L. D. M., Botros, M., Cassat, J. E., . . . Xie, C. (2023). The 2023 Orthopaedic Research Society's International Consensus Meeting on musculoskeletal infection: Summary from the host immunity section.. J Orthop Res, 42(3), 518-530.
DOI Scopus13 WoS12 Europe PMC11
2023 Zelmer, A., Starczak, Y., Solomon, L., Richter, K., Yang, D., & Atkins, G. (2023). Culture of Saos-2 cells under hypoxic conditions stimulates rapid differentiation to an osteocyte-like stage.
DOI
2023 Muratovic, D., Findlay, D. M., Quinn, M. J., Quarrington, R. D., Solomon, L. B., & Atkins, G. J. (2023). Microstructural and cellular characterisation of the subchondral trabecular bone in human knee and hip osteoarthritis using synchrotron tomography. Osteoarthritis and Cartilage, 31(9), 1224-1233.
DOI Scopus5 WoS5 Europe PMC1
2022 Ormsby, R. T., Hosaka, K., Evdokiou, A., Odysseos, A., Findlay, D. M., Solomon, L. B., & Atkins, G. J. (2022). The Effects of Vitamin E Analogues α-Tocopherol and γ-Tocotrienol on the Human Osteocyte Response to Ultra-High Molecular Weight Polyethylene Wear Particles. Prosthesis, 4(3), 480-489.
DOI Scopus2 WoS2
2022 Bennett, K. J., Pizzolato, C., Martelli, S., Bahl, J. S., Sivakumar, A., Atkins, G. J., . . . Thewlis, D. (2022). EMG-informed neuromusculoskeletal models accurately predict knee loading measured using instrumented implants. IEEE Transactions on Biomedical Engineering, 69(7), 2268-2275.
DOI Scopus51 WoS50 Europe PMC26
2022 Bliuc, D., Tran, T., Adachi, J. D., Atkins, G. J., Berger, C., van den Bergh, J., . . . CaMos Research Group. (2022). The association between cognitive decline and bone loss and fracture risk is not affected by medication with anticholinergic effect.. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 37(5), 1075-1076.
DOI
2022 Muratovic, D., Findlay, D. M., Quarrington, R. D., Cao, X., Solomon, L. B., Atkins, G. J., & Kuliwaba, J. S. (2022). Elevated levels of active Transforming Growth Factor β1 in the subchondral bone relate spatially to cartilage loss and impaired bone quality in human knee osteoarthritis. Osteoarthritis and Cartilage, 30(6), 896-907.
DOI Scopus17 WoS15 Europe PMC10
2022 Ormsby, R., Hosaka, K., Evdokiou, A., Odysseos, A., Findlay, D., Solomon, L., & Atkins, G. (2022). The Effects of Vitamin E Analogues α-Tocopherol and γ-Tocotrienol on the Human Osteocyte Response to Ultra-high Molecular Weight Polyethylene Wear Particles.
DOI
2022 Hofstaetter, J. G., Atkins, G. J., Kato, H., Kogawa, M., Blouin, S., Misof, B. M., . . . Ito, N. (2022). A Mild Case of Autosomal Recessive Osteopetrosis Masquerading as the Dominant Form Involving Homozygous Deep Intronic Variations in the CLCN7 Gene. Calcified Tissue International, 111(4), 430-444.
DOI Scopus3 WoS3 Europe PMC3
2022 Grace, T. M., Solomon, L. B., Atkins, G. J., Thewlis, D., & Taylor, M. (2022). Assigning trabecular bone material properties in finite element models simulating the pelvis before and after the development of peri-prosthetic osteolytic lesions. Journal of the Mechanical Behavior of Biomedical Materials, 133, 1-13.
DOI Scopus2 WoS2 Europe PMC2
2022 Alshabrawy, A. K., Cui, Y., Sylvester, C., Yang, D., Petito, E. S., Barratt, K. R., . . . Anderson, P. H. (2022). Therapeutic Potential of a Novel Vitamin D3 Oxime Analogue, VD1-6, with CYP24A1 Enzyme Inhibitory Activity and Negligible Vitamin D Receptor Binding. Biomolecules, 12(7), 1-14.
DOI Scopus7 WoS8 Europe PMC8
2022 Zelmer, A. R., Nelson, R., Richter, K., & Atkins, G. J. (2022). Can intracellular Staphylococcus aureus in osteomyelitis be treated using current antibiotics? A systematic review and narrative synthesis. Bone Research, 10(53), 1-18.
DOI Scopus73 WoS70 Europe PMC59
2022 Bennett, K. J., Callary, S. A., Atkins, G. J., Martelli, S., Perilli, E., Bogdan Solomon, L., & Thewlis, D. (2022). Ex vivo assessment of surgically repaired tibial plateau fracture displacement under axial load using large-volume micro-CT. Journal of Biomechanics, 144, 111275-1-111275-10.
DOI Scopus3 WoS3 Europe PMC2
2021 Prideaux, M., Wright, C., Noonan, M., Yi, X., Clinkenbeard, E., Mevel, E., . . . Thompson, W. (2021). Generation of Two Multipotent Mesenchymal Progenitor Cell Lines Capable of Osteogenic, Mature Osteocyte, Adipogenic, and Chondrogenic Differentiation.
DOI
2021 Muratovic, D., Findlay, D. M., Quarrington, R. D., Cao, X., Solomon, L. B., Atkins, G. J., & Kuliwaba, J. S. (2021). Elevated levels of active Transforming Growth Factor β1 in the subchondral bone relate spatially to cartilage loss and impaired bone quality in human knee osteoarthritis.
DOI
2021 Bliuc, D., Tran, T., Adachi, J. D., Atkins, G. J., Berger, C., van den Bergh, J., . . . Canadian Multicentre Osteoporosis Study (CaMos) Research Group. (2021). Cognitive decline is associated with an accelerated rate of bone loss and increased fracture risk in women: a prospective study from the Canadian Multicentre Osteoporosis Study. Journal of Bone and Mineral Research, 36(11), 2106-2115.
DOI Scopus36 WoS35 Europe PMC35
2021 Edwards, D. F., Miller, C. J., Quintana‐Martinez, A., Wright, C. S., Prideaux, M., Atkins, G. J., . . . Clinkenbeard, E. L. (2021). Differential iron requirements for osteoblast and adipocyte differentiation. JBMR Plus, 5(9), e10529-1-e10529-11.
DOI Scopus17 WoS16 Europe PMC13
2021 Bennett, K. J., Millar, S., Fraysse, F., Arnold, J., Atkins, G., Solomon, L., . . . Thewlis, D. (2021). Postoperative lower limb joint kinematics following tibial plateau fracture: a 2-year longitudinal study. Gait and Posture, 83, 20-25.
DOI Scopus13 WoS12 Europe PMC8
2021 Barratt, K. R., Sawyer, R. K., Atkins, G. J., St-Arnaud, R., & Anderson, P. H. (2021). Vitamin D supplementation improves bone mineralisation independent of dietary phosphate in male X-linked hypophosphatemic (Hyp) mice. Bone, 143(115767), 115767-1-115767-9.
DOI Scopus9 WoS7 Europe PMC7
2021 Stapledon, C. J. M., Stamenkov, R., Cappai, R., Clark, J. M., Bourke, A., Bogdan Solomon, L., & Atkins, G. J. (2021). Relationships between the bone expression of Alzheimer's disease-related genes, bone remodelling genes and cortical bone structure in neck of femur fracture. Calcified Tissue International, 108(5), 610-621.
DOI Scopus18 WoS19 Europe PMC17
2021 Maher, S., Wijenayaka, A. R., Lima-Marques, L., Yang, D., Atkins, G. J., & Losic, D. (2021). Advancing of Additive-Manufactured Titanium Implants with Bioinspired Micro- to Nanotopographies. ACS Biomaterials Science & Engineering, 7(2), 441-450.
DOI Scopus40 WoS37 Europe PMC19
2021 Ito, N., Prideaux, M., Wijenayaka, A. R., Yang, D., Ormsby, R. T., Bonewald, L. F., & Atkins, G. J. (2021). Sclerostin directly stimulates osteocyte aynthesis of fibroblast growth factor-23. Calcified Tissue International, 109(1), 66-76.
DOI Scopus36 WoS33 Europe PMC31
2021 Noonan, M. L., Ni, P., Agoro, R., Sacks, S. A., Swallow, E. A., Wheeler, J. A., . . . White, K. E. (2021). The HIF-PHI BAY 85-3934 (Molidustat) improves anemia and is associated with reduced levels of circulating FGF23 in a CKD mouse model.. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 36(6), 1117-1130.
DOI Scopus25 WoS23 Europe PMC20
2021 Tippen, S. P., Noonan, M. L., Ni, P., Metzger, C. E., Swallow, E. A., Sacks, S. A., . . . White, K. E. (2021). Age and sex effects on FGF23-mediated response to mild phosphate challenge. Bone, 146, 115885-1-115885-8.
DOI Scopus19 WoS19 Europe PMC20
2021 Starczak, Y., Reinke, D. C., Barratt, K. R., Russell, P. K., Clarke, M. V., Davey, R. A., . . . Anderson, P. H. (2021). Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male mice. Journal of Steroid Biochemistry and Molecular Biology, 210(105857), 1-7.
DOI Scopus12 WoS10 Europe PMC8
2021 Grace, T. M., O'Rourke, D., Robertson, T., Perilli, E., Callary, S., Taylor, M., . . . Thewlis, D. (2021). A semi-automated method to quantitatively assess osteolytic lesion volume and bone mineral density within acetabular regions of interest from CT. Journal of Orthopaedic Research, 40(2), 1-13.
DOI Scopus4 WoS5 Europe PMC2
2021 Ormsby, R. T., Zelmer, A. R., Yang, D., Gunn, N. J., Starczak, Y., Kidd, S. P., . . . Atkins, G. J. (2021). Evidence for osteocyte-mediated bone-matrix degradation associated with periprosthetic joint infection (PJI). European Cells and Materials, 41, 264-280.
DOI Scopus16 WoS17 Europe PMC16
2021 Gunn, N. J., Zelmer, A. R., Kidd, S. P., Solomon, L. B., Roscioli, E., Yang, D., & Atkins, G. J. (2021). A Human Osteocyte Cell Line Model for Studying Staphylococcus aureus Persistence in Osteomyelitis. Frontiers in Cellular and Infection Microbiology, 11, 781022-1-781022-10.
DOI Scopus14 WoS13 Europe PMC16
2021 Prideaux, M., Wright, C. S., Noonan, M. L., Yi, X., Clinkenbeard, E. L., Mevel, E., . . . Thompson, W. R. (2021). Generation of two multipotent mesenchymal progenitor cell lines capable of osteogenic, mature osteocyte, adipogenic, and chondrogenic differentiation. Scientific Reports, 11(1), 22593-1-22593-16.
DOI Scopus14 WoS14 Europe PMC16
2021 Kitchen, D. S., Richards, J., Smitham, P. J., Atkins, G. J., & Solomon, L. B. (2021). Does time to theatre affect the ability to achieve fracture reduction in tibial plateau fractures?. Journal of Clinical Medicine, 11(1), 138-1-138-13.
DOI Scopus6 WoS5 Europe PMC3
2021 Day, C. W., Costi, K., Pannach, S., Atkins, G. J., Hofstaetter, J. G., Callary, S. A., . . . Solomon, L. B. (2021). Long-term outcomes of staged revision surgery for chronic periprosthetic joint infection of total hip arthroplasty. Journal of Clinical Medicine, 11(1), 122-1-122-14.
DOI Scopus19 WoS19 Europe PMC12
2020 Prideaux, M., Wright, C., Noonan, E., Yi, X., Clinkenbeard, E., Mevel, E., . . . Thompson, W. (2020). Generation of two multipotent Mesenchymal Progenitor Cell Lines Capable of Osteogenic, Mature Osteocyte, Adipogenic, and Chondrogenic Differentiation. BioRxiv.
DOI
2020 Stapledon, C. J. M., Stamenkov, R., Cappai, R., Clark, J. M., Bourke, A., Solomon, L. B., & Atkins, G. J. (2020). Relationships between the Bone Expression of Alzheimer Disease-Related Genes, Bone Remodelling Genes and Cortical Bone Structure in Neck of Femur Fracture. biorxiv.
DOI
2020 Ito, N., Prideaux, M., Wijenayaka, A., Yang, D., Ormsby, R., Bonewald, L., & Atkins, G. (2020). Sclerostin directly stimulates osteocyte synthesis of fibroblast growth factor-23.
DOI
2020 Callary, S. A., Jones, C. F., Kantar, K., Du Toit, H., Baker, M. P., Thewlis, D., . . . Solomon, L. B. (2020). A new approach to surgical management of tibial plateau fractures. Journal of Clinical Medicine, 9(3), 626-1-626-9.
DOI Scopus10 WoS5 Europe PMC6
2020 Hofstee, M. I., Muthukrishnan, G., Atkins, G. J., Riool, M., Thompson, K., Morgenstern, M., . . . Moriarty, T. F. (2020). Current concepts of osteomyelitis: from pathological mechanisms to advanced research methods.. The American journal of pathology, 190(6), 13 pages.
DOI Scopus122 WoS108 Europe PMC83
2020 Rastin, H., Ormsby, R. T., Atkins, G. J., & Losic, D. (2020). 3D bioprinting of methylcellulose/gelatin-methacryloyl (MC/GelMA) bioink with high shape integrity. ACS Applied Bio Materials, 3(3), 1815-1826.
DOI Scopus135 WoS119 Europe PMC84
2019 Ormsby, R. T., Solomon, L. B., Yang, D., Crotti, T. N., Haynes, D. R., Findlay, D. M., & Atkins, G. J. (2019). Osteocytes respond to particles of clinically-relevant conventional and cross-linked polyethylene and metal alloys by up-regulation of resorptive and inflammatory pathways. Acta Biomaterialia, 87, 296-306.
DOI Scopus55 WoS46 Europe PMC39
2019 Yang, D., Gronthos, S., Isenmann, S., Morris, H. A., & Atkins, G. J. (2019). The late osteoblast/preosteocyte cell line MLO-A5 displays mesenchymal lineage plasticity in vitro and in vivo. Stem Cells International, 2019(9838167), 9838167-1-9838167-10.
DOI Scopus4 WoS3 Europe PMC2
2019 Smitham, P. J., Vohora, A., Howie, D. W., Atkins, G. J., & Solomon, L. B. (2019). Surgical Technique to Manage Periprosthetic Fractures of the Knee in Patients with Infected Leg Ulcers. Jbjs Case Connector, 9(3), E0347.
DOI
2019 Atkins, G., Alberdi, M., Beswick, A., Blaha, J., Bingham, J., Cashman, J., . . . Wyatt, M. (2019). General Assembly, Prevention, Surgical Site Preparation: Proceedings of International Consensus on Orthopedic Infections. Journal of Arthroplasty, 34(2), 85-92.
DOI Scopus15 WoS14 Europe PMC11
2019 Stapledon, C. J. M., Tsangari, H., Solomon, L. B., Campbell, D. G., Hurtado, P., Krishnan, R., & Atkins, G. J. (2019). Human osteocyte expression of Nerve Growth Factor: the effect of Pentosan Polysulphate Sodium (PPS) and implications for pain associated with knee osteoarthritis. PLoS ONE, 14(9), e0222602-1-e0222602-15.
DOI Scopus18 WoS16 Europe PMC14
2019 Sharma, D. K., Sawyer, R. K., Robertson, T. S., Stamenkov, R., Solomon, L. B., Atkins, G. J., . . . Anderson, P. H. (2019). Elevated Serum 25-Hydroxyvitamin D Levels Are Associated with Improved Bone Formation and Micro-Structural Measures in Elderly Hip Fracture Patients.. Journal of clinical medicine, 8(11), 10 pages.
DOI Scopus16 WoS12 Europe PMC10
2019 Brown, P., Tan, A. -C., El-Esawi, M. A., Liehr, T., Blanck, O., Gladue, D. P., . . . Zhou, Y. (2019). Large expert-curated database for benchmarking document similarity detection in biomedical literature search. Database: the journal of biological databases and curation, 2019(baz085), baz085-1-baz085-66.
DOI Scopus28 WoS36 Europe PMC13
2019 Ormsby, R. T., Solomon, L. B., Stamenkov, R., Findlay, D. M., & Atkins, G. J. (2019). Evidence for gender-specific bone loss mechanisms in periprosthetic osteolysis. Journal of Clinical Medicine, 9(1), 1-15.
DOI Scopus7 WoS7 Europe PMC3
2018 Yang, D., Wijenayaka, A., Solomon, L., Pederson, S., Findlay, D., Kidd, S., & Atkins, G. (2018). Novel insights into Staphylococcus aureus deep bone infections: the involvement of osteocytes. mBio, 9(2), e00415-18-1-e00415-18-10.
DOI Scopus143 WoS136 Europe PMC116
2018 Solomon, L., Kitchen, D., Anderson, P., Yang, D., Starczak, Y., Kogawa, M., . . . Atkins, G. (2018). Time dependent loss of trabecular bone in human tibial plateau fractures. Journal of Orthopaedic Research, 36(11), 2865-2875.
DOI Scopus3 WoS3 Europe PMC3
2018 Qin, J., Yang, D., Maher, S., Lima-Marques, L., Zhou, Y., Chen, Y., . . . Losic, D. (2018). Micro- and nano-structured 3D printed titanium implants with a hydroxyapatite coating for improved osseointegration. Journal of Materials Chemistry B, 6(19), 3136-3144.
DOI Scopus83 WoS73 Europe PMC34
2018 Yang, D., Wijenayaka, A., & Atkins, G. (2018). A fluorometric method for the quantification of cell number in complex differentiating osteoblast-osteocyte cultures. Methods and Protocols, 1(2), 14.
DOI Scopus1 WoS1
2018 Starczak, Y., Reinke, D., Barratt, K., Ryan, J., St-Arnaud, R., Morris, H., . . . Anderson, P. (2018). Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss. Journal of Steroid Biochemistry and Molecular Biology, 177, 77-82.
DOI Scopus22 WoS17 Europe PMC14
2018 Yang, D., Anderson, P., Wijenayaka, A., Barratt, K., Triliana, R., Stapledon, C., . . . Atkins, G. (2018). Both ligand and VDR expression levels critically determine the effect of 1α,25-dihydroxyvitamin-D₃ on osteoblast differentiation. Journal of Steroid Biochemistry and Molecular Biology, 177, 83-90.
DOI Scopus17 WoS13 Europe PMC11
2018 Kogawa, M., Khalid, K., Wijenayaka, A., Ormsby, R., Evdokiou, A., Anderson, P., . . . Atkins, G. (2018). Recombinant sclerostin antagonises effects of ex vivo mechanical loading in trabecular bone and increases osteocyte lacunar size. American Journal of Physiology - Cell Physiology, 314(1), 53-61.
DOI Scopus29 WoS27 Europe PMC22
2017 Thewlis, D., Fraysse, F., Callary, S., Verghese, V., Jones, C., Findlay, D., . . . Solomon, L. (2017). Postoperative weight bearing and patient reported outcomes at one year following tibial plateau fractures. Injury, 48(7), 1650-1656.
DOI Scopus34 WoS28 Europe PMC27
2017 Reinke, D., Starczak, Y., Kogawa, M., Barratt, K., Morris, H., Anderson, P., & Atkins, G. (2017). Evidence for altered osteoclastogenesis in splenocyte cultures from VDR knockout mice. Journal of Steroid Biochemistry and Molecular Biology, 177, 96-102.
DOI Scopus3 WoS2 Europe PMC1
2017 Liapis, V., Zysk, A., DeNichilo, M., Zinonos, I., Hay, S., Panagopoulos, V., . . . Evdokiou, A. (2017). Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma. Cancer Medicine, 6(9), 2164-2176.
DOI Scopus9 WoS9 Europe PMC8
2017 Panagopoulos, V., Liapis, V., Zinonos, I., Hay, S., Leach, D. A., Ingman, W., . . . Evdokiou, A. (2017). Peroxidase enzymes inhibit osteoclast differentiation and bone resorption. Molecular and Cellular Endocrinology, 440(C), 8-15.
DOI Scopus17 WoS18 Europe PMC15
2017 Zysk, A., DeNichilo, M., Panagopoulos, V., Zinonos, I., Liapis, V., Hay, S., . . . Evdokiou, A. (2017). Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer. Cancer Letters, 386, 141-150.
DOI Scopus23 WoS21 Europe PMC20
2017 Gulati, K., Prideaux, M., Kogawa, M., Lima-Marques, L., Atkins, G. J., Findlay, D. M., & Losic, D. (2017). Anodized 3D-printed titanium implants with dual micro- and nano-scale topography promote interaction with human osteoblasts and osteocyte-like cells. Journal of Tissue Engineering and Regenerative Medicine, 11(12), 3313-3325.
DOI Scopus94 WoS85 Europe PMC51
2016 Rahman, S., Gulati, K., Kogawa, M., Atkins, G., Pivonka, P., Findlay, D., & Losic, D. (2016). Drug diffusion, integration, and stability of nanoengineered drug-releasing implants in bone ex-vivo. Journal of Biomedical Materials Research Part A, 104(3), 714-725.
DOI Scopus36 WoS31 Europe PMC21
2016 Triliana, R., Lam, N., Sawyer, R., Atkins, G., Morris, H., & Anderson, P. (2016). Skeletal characterization of an osteoblast-specific vitamin D receptor transgenic (ObVDR-B6) mouse model. Journal of Steroid Biochemistry and Molecular Biology, 164, 331-336.
DOI Scopus12 WoS9 Europe PMC9
2016 Saad, S., Dharmapatni, A., Crotti, T., Cantley, M., Algate, K., Findlay, D., . . . Haynes, D. (2016). Semaphorin-3a, neuropilin-1 and plexin-A1 in prosthetic-particle induced bone loss. Acta Biomaterialia, 30, 311-318.
DOI Scopus22 WoS20 Europe PMC19
2016 DeNichilo, M., Shoubridge, A., Panagopoulos, V., Liapis, V., Zysk, A., Zinonos, I., . . . Evdokiou, A. (2016). Peroxidase enzymes regulate collagen biosynthesis and matrix mineralization by cultured human osteoblasts. Calcified Tissue International, 98(3), 294-305.
DOI Scopus14 WoS15 Europe PMC14
2016 Reinke, D., Kogawa, M., Barratt, K., Morris, H., Anderson, P., & Atkins, G. (2016). Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice. Journal of Steroid Biochemistry and Molecular Biology, 164, 353-360.
DOI Scopus12 WoS8 Europe PMC8
2016 Wijenayaka, A., Prideaux, M., Yang, D., Morris, H., Findlay, D., Anderson, P., & Atkins, G. (2016). Early response of the human SOST gene to stimulation by 1α,25-dihydroxyvitamin D₃. Journal of Steroid Biochemistry and Molecular Biology, 164, 369-373.
DOI Scopus14 WoS12 Europe PMC13
2016 Ryan, J., Starczak, Y., Tsangari, H., Sawyer, R., Davey, R., Atkins, G., . . . Anderson, P. (2016). Sex-related differences in the skeletal phenotype of aged vitamin D receptor global knockout mice. Journal of Steroid Biochemistry and Molecular Biology, 164, 361-368.
DOI Scopus14 WoS12 Europe PMC11
2016 Liapis, V., Zinonos, I., Labrinidis, A., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2016). Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models. Cancer Medicine, 5(3), 534-545.
DOI Scopus27 WoS24 Europe PMC22
2016 Ormsby, R., Cantley, M., Kogawa, M., Solomon, L., Haynes, D., Findlay, D., & Atkins, G. (2016). Evidence that osteocyte perilacunar remodelling contributes to polyethylene wear particle induced osteolysis. Acta Biomaterialia, 33, 242-251.
DOI Scopus66 WoS57 Europe PMC43
2016 Prideaux, M., Findlay, D., & Atkins, G. (2016). Osteocytes: the master cells in bone remodelling. Current Opinion in Pharmacology, 28, 24-30.
DOI Scopus172 WoS163 Europe PMC132
2016 Yang, D., Anderson, P., Turner, A., Morris, H., & Atkins, G. (2016). Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D₃ on the mature osteoblast cell line MLO-A5. Journal of Steroid Biochemistry and Molecular Biology, 164, 374-378.
DOI Scopus6 WoS5 Europe PMC5
2016 Prideaux, M., Schutz, C., Wijenayaka, A. R., Findlay, D. M., Campbell, D. G., Solomon, L. B., & Atkins, G. J. (2016). Isolation of osteocytes from human trabecular bone. Bone, 88, 64-72.
DOI Scopus37 WoS33 Europe PMC31
2016 Gulati, K., Kogawa, M., Prideaux, M., Findlay, D., Atkins, G., & Losic, D. (2016). Drug-releasing nano-engineered titanium implants: therapeutic efficacy in 3D cell culture model, controlled release and stability. Materials Science and Engineering C, 69, 831-840.
DOI Scopus65 WoS54 Europe PMC30
2016 Derrick-Roberts, A., Panir, K., Pyragius, C., Zarrinkalam, K., Atkins, G., & Byers, S. (2016). Reversal of established bone pathology in MPS VII mice following lentiviral-mediated gene therapy. Molecular Genetics and Metabolism, 119(3), 249-257.
DOI Scopus14 WoS14 Europe PMC15
2015 Ito, N., Wijenayaka, A., Prideaux, M., Kogawa, M., Ormsby, R., Evdokiou, A., . . . Atkins, G. (2015). Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli. Molecular and Cellular Endocrinology, 399(C), 208-218.
DOI Scopus149 WoS144 Europe PMC131
2015 Liapis, V., Labrinidis, A., Zinonos, I., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2015). Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma. Cancer Letters, 357(1), 160-169.
DOI Scopus44 WoS41 Europe PMC41
2015 Van De Pol, G., Iselin, L., Callary, S., Thewlis, D., Jones, C., Atkins, G., & Solomon, L. (2015). Impaction bone grafting has potential as an adjunct to the surgical stabilisation of osteoporotic tibial plateau fractures: early results of a case series. Injury, 46(6), 1089-1096.
DOI Scopus19 WoS16 Europe PMC15
2015 Rahman, S., Atkins, G., Findlay, D., & Losic, D. (2015). Nanoengineered drug releasing aluminium wire implants: a model study for localized bone therapy. Journal of Materials Chemistry B, 3(16), 3288-3296.
DOI Scopus14 WoS13 Europe PMC5
2015 Yang, D., Turner, A., Wijenayaka, A., Anderson, P., Morris, H., & Atkins, G. (2015). 1,25-Dihydroxyvitamin D₃ and extracellular calcium promote mineral deposition via NPP1 activity in a mature osteoblast cell line MLO-A5. Molecular and Cellular Endocrinology, 412(C), 140-147.
DOI Scopus23 WoS20 Europe PMC19
2015 Wijenayaka, A., Yang, D., Prideaux, M., Ito, N., Kogawa, M., Anderson, P., . . . Atkins, G. (2015). 1α,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion. Molecular and Cellular Endocrinology, 413(C), 157-167.
DOI Scopus44 WoS37 Europe PMC32
2015 Clarke, M., Russell, P., Findlay, D., Sastra, S., Anderson, P., Skinner, J., . . . Davey, R. (2015). A role for the Calcitonin respetor to limit bone loss during lactation in female mice by inhibiting osteocytic osteolysis. Endocrinology, 156(9), 3203-3214.
DOI Scopus48 WoS35 Europe PMC28
2015 Saji, V., Kumeria, T., Gulati, K., Prideaux, M., Rahman, S., Alsawat, M., . . . Losic, D. (2015). Localized drug delivery of selenium (Se) using nanoporous anodic aluminium oxide for bone implants. Journal of Materials Chemistry B, 3(35), 7090-7098.
DOI Scopus23 WoS23 Europe PMC7
2015 Yang, D., Atkins, G. J., Turner, A. G., Anderson, P. H., & Morris, H. A. (2015). Erratum: Differential effects of 1,25-dihydroxyvitamin D on mineralisation and differentiation in two different types of osteoblast-like cultures (Journal of Steroid Biochemistry and Molecular Biology (2013) 136 166-170). Journal of Steroid Biochemistry and Molecular Biology, 147, 125.
DOI
2015 Rahman, S., Ormsby, R., Santos, A., Atkins, G., Findlay, D., & Losic, D. (2015). Nanoengineered drug-releasing aluminium wire implants: comparative investigation of nanopore geometry, drug release and osteoblast cell adhesion. RSC Advances, 5(92), 75004-75014.
DOI Scopus6 WoS6
2014 Lam, N., Triliana, R., Sawyer, R., Atkins, G., Morris, H., O'Loughlin, P., & Anderson, P. (2014). Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency. Journal of Steroid Biochemistry and Molecular Biology, 144(PART A), 128-131.
DOI Scopus34 WoS27 Europe PMC25
2014 Prideaux, M., Wijenayaka, A., Kumarasinghe, D., Ormsby, R., Evdokiou, A., Findlay, D., & Atkins, G. (2014). SaOS2 osteosarcoma cells as an in vitro model for studying the transition of human osteoblasts to osteocytes. Calcified Tissue International, 95(2), 183-193.
DOI Scopus97 WoS96 Europe PMC78
2014 Zinonos, I., Luo, K., Labrinidis, A., Liapis, V., Hay, S., Panagopoulos, V., . . . Evdokiou, A. (2014). Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. International Journal of Oncology, 45(2), 532-540.
DOI Scopus20 WoS20 Europe PMC18
2014 Findlay, D. M., & Atkins, G. J. (2014). Osteoblast-chondrocyte interactions in osteoarthritis. Current Osteoporosis Reports, 12(1), 127-134.
DOI Scopus123 WoS115 Europe PMC104
2014 Ito, N., Findlay, D., & Atkins, G. (2014). Osteocyte communication with the kidney via the production of FGF23: Remote control of phosphate homeostasis. Clinical Reviews in Bone and Mineral Metabolism, 12(1), 44-58.
DOI Scopus9 WoS7
2014 Ito, N., Peña, A., Perano, S., Atkins, G., Findlay, D., & Couper, J. (2014). First Australian report of vitamin D-dependent rickets type I. Medical Journal of Australia, 201(7), 420-421.
DOI Scopus6 WoS4 Europe PMC3
2014 Zinonos, I., Labrinidis, A., Liapis, V., Hay, S., Panagopoulos, V., Denichilo, M., . . . Evdokiou, A. (2014). Doxorubicin overcomes resistance to drozitumab by antagonizing inhibitor of apoptosis proteins (IAPS). Anticancer Research, 34(12), 7007-7020.
Scopus9 WoS8 Europe PMC8
2014 Turner, A., Hanrath, M., Morris, H., Atkins, G., & Anderson, P. (2014). The local production of 1,25(OH)₂D₃ promotes osteoblast and osteocyte maturation. The Journal of Steroid Biochemistry and Molecular Biology, 144(Part A), 114-118.
DOI Scopus49 WoS40 Europe PMC36
2014 Ormsby, R., Findlay, D., Kogawa, M., Anderson, P., Morris, H., & Atkins, G. (2014). Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling. The Journal of Steroid Biochemistry and Molecular Biology, 144(Part A), 110-113.
DOI Scopus27 WoS25 Europe PMC18
2013 Yang, D., Atkins, G., Turner, A., Anderson, P., & Morris, H. (2013). Differential effects of 1,25-dihydroxyvitamin D on mineralisation and differentiation in two different types of osteoblast-like cultures. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 166-170.
DOI Scopus28 WoS24 Europe PMC18
2013 Kogawa, M., Findlay, D., Anderson, P., & Atkins, G. (2013). Modulation of osteoclastic migration by metabolism of 25(OH)-vitamin D₃. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 59-61.
DOI Scopus16 WoS13 Europe PMC9
2013 Anderson, P., Lam, N., Turner, A., Davey, R., Kogawa, M., Atkins, G., & Morris, H. (2013). The pleiotropic effects of vitamin D in bone. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 190-194.
DOI Scopus56 WoS46 Europe PMC38
2013 Kato, N., Matsumoto, M., Kogawa, M., Atkins, G., Findlay, D., Fujikawa, T., . . . Ogata, M. (2013). Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo. Journal of Neuroinflammation, 10(1), 1-13.
DOI Scopus49 WoS46 Europe PMC52
2013 Ryan, J., Reinke, D., Kogawa, M., Turner, A., Atkins, G., Anderson, P., & Morris, H. (2013). Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts. Current Drug Targets, 14(14), 1683-1688.
DOI Scopus21 WoS22 Europe PMC18
2013 Kogawa, M., Wijenayaka, A., Ormsby, R., Thomas, G., Anderson, P., Bonewald, L., . . . Atkins, G. (2013). Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2. Journal of Bone and Mineral Research, 28(12), 2436-2448.
DOI Scopus142 WoS128 Europe PMC110
2013 Howie, D., Neale, S., Haynes, D., Holubowycz, O., McGee, M., Solomon, L., . . . Findlay, D. (2013). Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management. Inflammopharmacology, 21(6), 389-396.
DOI Scopus40 WoS35 Europe PMC28
2013 Kogawa, M., Hisatake, K., Atkins, G., Findlay, D., Enoki, Y., Sato, T., . . . Matsumoto, M. (2013). The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-kB ligand (RANKL)-induced Osteoclast differentiation. Journal of Biological Chemistry, 288(43), 31299-31312.
DOI Scopus21 WoS21 Europe PMC15
2013 Welldon, K., Findlay, D., Evdokiou, A., Ormsby, R., & Atkins, G. (2013). Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. Molecular and Cellular Endocrinology, 376(1), 85-92.
DOI Scopus28 WoS29 Europe PMC25
2013 Ito, N., Findlay, D., Anderson, P., Bonewald, L., & Atkins, G. (2013). Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D₃ (1,25D) on osteocyte like cells. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 183-186.
DOI Scopus52 WoS47 Europe PMC48
2012 Gulati, K., Ramakrishnan, S., Aw, M., Atkins, G., Findlay, D., & Losic, D. (2012). Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion. Acta Biomaterialia, 8(1), 449-456.
DOI Scopus287 WoS256 Europe PMC127
2012 Kumarasinghe, D., Sullivan, T., Kuliwaba, J., Fazzalari, N., & Atkins, G. (2012). Evidence for the dysregulated expression of TWIST1, TGFβ1 and SMAD3 in differentiating osteoblasts from primary hip osteoarthritis patients. Osteoarthritis and Cartilage, 20(11), 1357-1366.
DOI Scopus29 WoS28 Europe PMC22
2012 Aw, M., Khalid, K., Gulati, K., Atkins, G., Pivonka, P., Findlay, D., & Losic, D. (2012). Characterization of drug-release kinetics in trabecular bone from titania nanotube implants. International Journal of Nanomedicine (online), 7, 4883-4892.
DOI Scopus56 WoS46 Europe PMC20
2012 Atkins, G., & Findlay, D. (2012). Osteocyte regulation of bone mineral: a little give and take. Osteoporosis International, 23(8), 2067-2079.
DOI Scopus137 WoS113 Europe PMC100
2012 Alias, E., Dharmapatni, A., Holding, C., Atkins, G., Findlay, D., Howie, D., . . . Haynes, D. (2012). Polyethylene particles stimulate expression of ITAM-related molecules in peri-implant tissues and when stimulating osteoclastogenesis in vitro. Acta Biomaterialia, 8(8), 3104-3112.
DOI Scopus21 WoS19 Europe PMC20
2012 Zarrinkalam, M., Mulaibrahimovic, A., Atkins, G., & Moore, R. (2012). Changes in osteocyte density correspond with changes in osteoblast and osteoclast activity in an osteoporotic sheep model. Osteoporosis International, 23(0004), 1329-1336.
DOI Scopus48 WoS44 Europe PMC36
2012 Bhattacharjee, M., Raju, R., Radhakrishnan, A., Nanjappa, V., Muthusamy, B., Singh, K., . . . Chatterjee, A. (2012). A bioinformatics resource for TWEAK-Fn14 signaling pathway. Journal of Signal Transduction, 2012, 376470-1-376470-10.
DOI
2011 Atkins, G., Haynes, D., Howie, D., & Findlay, D. (2011). Role of polyethylene particles in peri-prosthetic osteolysis: A review. World Journal of Orthopedics, 2(10), 93-101.
DOI Scopus52 WoS40 Europe PMC32
2011 Kumarasinghe, D., Hopwood, B., Kuliwaba, J., Atkins, G., & Fazzalari, N. (2011). An update on primary hip osteoarthritis including altered Wnt and TGF-beta associated gene expression from the bony component of the disease. Rheumatology, 50(12), 2166-2175.
DOI Scopus15 WoS14 Europe PMC14
2011 Anderson, P., Atkins, G., Turner, A., Kogawa, M., Findlay, D., & Morris, H. (2011). Vitamin D metabolism within bone cells: Effects on bone structure and strength. Molecular and Cellular Endocrinology, 347(1-2 Sp Is), 42-47.
DOI Scopus56 WoS54 Europe PMC34
2011 Wijenayaka, A., Kogawa, M., Lim, H., Bonewald, L., Findlay, D., & Atkins, G. (2011). Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS One, 6(10), e25900-1-e25900-9.
DOI Scopus440 WoS403 Europe PMC344
2011 Findlay, D., & Atkins, G. (2011). Relationship between serum RANKL and RANKL in bone. Osteoporosis International, 22(10), 2597-2602.
DOI Scopus65 WoS60 Europe PMC48
2011 Dharmapatni, A., Smith, M., Crotti, T., Holding, C., Vincent, C., Weedon, H., . . . Haynes, D. (2011). TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis. Arthritis Research & Therapy, 13(2), R51-1-R51-10.
DOI Scopus40 WoS37 Europe PMC35
2011 Atkins, G., Rowe, P., Lim, H., Welldon, K., Ormsby, R., Wijenayaka, A., . . . Findlay, D. (2011). Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. Journal of Bone and Mineral Research, 26(7), 1425-1436.
DOI Scopus213 WoS194 Europe PMC169
2010 Kumarasinghe, D., Perilli, E., Tsangari, H., Truong, L., Kuliwaba, J., Hopwood, B., . . . Fazzalari, N. (2010). Critical molecular regulators, histomorphometric indices and their correlations in the trabecular bone in primary hip osteoarthritis. Osteoarthritis and Cartilage, 18(10), 1337-1344.
DOI Scopus26 WoS25 Europe PMC23
2010 Kogawa, M., Findlay, D., Anderson, P., Ormsby, R., Vincent, C., Morris, H., & Atkins, G. (2010). Osteoclastic metabolism of 25(OH)-vitamin D-3: A potential mechanism for optimization of bone resorption. Endocrinology, 151(10), 4613-4625.
DOI Scopus131 WoS111 Europe PMC88
2010 Kataria, N., Bartold, P., Dharmapatni, A., Atkins, G., Holding, C., & Haynes, D. (2010). Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis. Journal of Periodontal Research, 45(4), 564-573.
DOI Scopus22 WoS22 Europe PMC17
2010 Williams, S., Martin, S., Vincent, C., Gronthos, S., Zheng, T., Atkins, G., & Zannettino, A. (2010). Circulating levels of TWEAK correlate with bone erosion in multiple myeloma patients. British Journal of Haematology, 150(3), 373-376.
DOI Scopus6 WoS6 Europe PMC4
2010 Kogawa, M., Anderson, P., Findlay, D., Morris, H., & Atkins, G. (2010). The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts. Journal of Steroid Biochemistry and Molecular Biology, 121(1-2 Sp Iss), 277-280.
DOI Scopus69 WoS55 Europe PMC45
2009 Atkins, G., Welldon, K., Wijenayaka, A., Bonewald, L., & Findlay, D. (2009). Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by y-carboxylation-dependent and -independent mechanisms. American Journal of Physiology-Cell Physiology, 297(6), C1358-C1367.
DOI Scopus110 WoS106 Europe PMC88
2009 Vincent, C., Findlay, D., Welldon, K., Wijenayaka, A., Zheng, T., Haynes, D., . . . Atkins, G. (2009). Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNF alpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. Journal of Bone and Mineral Research, 24(8), 1434-1449.
DOI Scopus160 WoS156 Europe PMC132
2009 Wijenayaka, A., Colby, C., Atkins, G., & Majewski, P. (2009). Biomimetic hydroxyapatite coating on glass coverslips for the assay of osteoclast activity in vitro. Journal of Materials Science-Materials in Medicine, 20(7), 1467-1473.
DOI Scopus13 WoS13 Europe PMC7
2009 Atkins, G., Welldon, K., Holding, C., Haynes, D., Howie, D., & Findlay, D. (2009). The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles. Biomaterials, 30(22), 3672-3681.
DOI Scopus92 WoS88 Europe PMC82
2009 Labrinidis, A., Diamond, P., Martin, S., Hay, S., Liapis, V., Zinonos, I., . . . Evdokiou, A. (2009). Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma. Clinical Cancer Research, 15(6), 1998-2009.
DOI Scopus33 WoS31 Europe PMC30
2009 Vincent, C., Kogawa, M., Findlay, D., & Atkins, G. (2009). The generation of osteoclasts from RAW 264.7 precursors in defined, serum-free conditions. Journal of Bone and Mineral Metabolism, 27(1), 114-119.
DOI Scopus57 WoS52 Europe PMC46
2009 Atkins, G., Welldon, K., Halbout, P., & Findlay, D. (2009). Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. Osteoporosis International, 20(4), 653-664.
DOI Scopus183 WoS167 Europe PMC131
2009 Anderson, P., Sawyer, R., Moore, A., Atkins, G., O'Loughlin, P., & Morris, H. (2009). Osteocyte cell density is reduced during vitamin D depletion and predicts osteoclast surface and bone mineral volume. Bone: cell molecular biology; pathophysiology; treatment, 44(Supplement 1), S131.
DOI
2008 Moffatt, P., Gaumond, M., Salois, P., Sellin, K., Bessette, M., Godin, E., . . . Thomas, G. (2008). Bril: A novel bone-specific modulator of mineralization. Journal of Bone and Mineral Research, 23(9), 1497-1508.
DOI Scopus134 WoS130 Europe PMC121
2008 Davey, R., Turner, A., McManus, J., Chiu, W., Tjahyono, F., Moore, A., . . . Zajac, J. (2008). Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice. Journal of Bone and Mineral Research, 23(8), 1182-1193.
DOI Scopus90 WoS76 Europe PMC54
2008 Welldon, K., Atkins, G., Howie, D., & Finlay, D. (2008). Primary human osteoblasts grow into porous tantalum and maintain an osteoblastic phenotype. Journal of Biomedical Materials Research. Part A, 84A(3), 691-701.
DOI Scopus89 WoS77 Europe PMC49
2008 Anderson, P., & Atkins, G. (2008). The skeleton as an intracrine organ for vitamin D metabolism. Molecular Aspects of Medicine, 29(6), 397-406.
DOI Scopus84 WoS81 Europe PMC63
2008 Labrinidis, A., Liapis, V., Thai, L., Atkins, G., Vincent, C., Hay, S., . . . Evdokiou, A. (2008). Does Apo2LTRAIL play any physiologic role in osteoclastogenesis?. Blood, 111(11), 5411-5412.
DOI Scopus19 WoS15 Europe PMC10
2007 Atkins, G., Anderson, P., Findlay, D., Welldon, K., Vincent, C., Zannettino, A., . . . Morris, H. (2007). Metabolism of vitamin D₃ in human osteoblasts: Evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D₃. Bone, 40(6), 1517-1528.
DOI Scopus228 WoS201 Europe PMC173
2007 Anderson, P., Atkins, G., Findlay, D., O'Loughlin, P., Welldon, K., Vincent, C., & Morris, H. (2007). RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)₂D₃ synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells. Journal of Steroid Biochemistry and Molecular Biology, 103(3-5 Sp Iss), 601-605.
DOI Scopus43 WoS35 Europe PMC28
2007 Atkins, G. J., Welldon, K. J., & Findlay, D. M. (2007). Strontium ranelate promotes an osteocyte-like phenotype from human primary osteoblasts ex vivo. CALCIFIED TISSUE INTERNATIONAL, 80, S71-S72.
2006 Holding, C., Findlay, D., Stamenkov, R., Neale, S., Lucas, H., Dharmapatni, A., . . . Haynes, D. (2006). The correlation of RANK, RANKL and TNFα expression with bone loss volume and polyethylene wear debris around hip implants. Biomaterials, 27(30), 5212-5219.
DOI Scopus116 WoS107 Europe PMC93
2006 Atkins, G., Kostakis, P., Vincent, C., Farrugia, A., Houchins, J., Findlay, D., . . . Zannettino, A. (2006). RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. Journal of Bone and Mineral Research, 21(9), 1339-1349.
DOI Scopus116 WoS111 Europe PMC104
2006 Perper, S., Browning, B., Burkly, L., Weng, S., Gao, C., Giza, K., . . . Hess, H. (2006). TWEAK is a novel arthritogenic mediator. Journal of Immunology, 177(4), 2610-2620.
DOI Scopus145 WoS138 Europe PMC118
2005 Zannettino, A., Holding, C., Diamond, P., Atkins, G., Kostakis, P., Farrugia, A., . . . Haynes, D. (2005). Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor. Journal of Cellular Physiology, 204(2), 714-723.
DOI Scopus146 WoS145 Europe PMC117
2005 Morgan, T., Atkins, G., Trivett, M., Johnson, S., Kansara, M., Schlicht, S., . . . Thomas, D. (2005). Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kB. American Journal of Pathology, 167(1), 117-128.
DOI Scopus121 WoS107 Europe PMC96
2005 Atkins, G., Kostakis, P., Welldon, K., Vincent, C., Findlay, D., & Zannettino, A. (2005). Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. Journal of Cellular Physiology, 203(3), 573-582.
DOI Scopus30 WoS30 Europe PMC30
2004 Zannettino, A., Pan, B., Farrugia, A., Atkins, G., & To, L. (2004). Identification and clinical relevance of receptor activator of nuclear factor kappa B ligand expression of myeloma cells - Reply. Cancer Research, 64(2), 774-775.
2004 Tsangari, H., Findlay, D., Kuliwaba, J., Atkins, G., & Fazzalari, N. (2004). Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. Bone, 35(1), 334-342.
DOI Scopus57 WoS55 Europe PMC46
2004 Bouralexis, S., Clayer, M., Atkins, G., Labrinidis, A., Hay, S., Graves, S., . . . Evdokiou, A. (2004). Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin. International Journal of Oncology, 24(5), 1263-1270.
DOI Scopus14 WoS14 Europe PMC11
2004 Findlay, D., Welldon, K., Atkins, G., Howie, D., Zannettino, A., & Bobyn, D. (2004). The proliferation and phenotypic expression of human osteoblasts on tantalum metal. Biomaterials, 25(12), 2215-2227.
DOI Scopus195 WoS172 Europe PMC99
2004 Pan, B., To, L., Farrugia, A., Findlay, D., Green, J., Gronthos, S., . . . Zannettino, A. (2004). The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone, 34(1), 112-123.
DOI Scopus106 WoS96 Europe PMC76
2004 Hu, Y., Zhou, H., Myers, D., Quinn, J., Atkins, G., Ly, C., . . . Ng, K. (2004). Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts. Journal of Bone and Mineral Research, 19(1), 89-99.
DOI Scopus45 WoS41 Europe PMC39
2004 Heider, U., Zavrski, I., Jakob, C., Fleissner, C., Sezer, O., Zannettino, A. C. W., . . . Bik To, L. (2004). Identification and Clinical Relevance of Receptor Activator of Nuclear Factor κB Ligand Expression of Myeloma Cells [2] (multiple letters). Cancer Research, 64(2), 773-775.
DOI Scopus1 Europe PMC1
2003 Haynes, D., Barg, E., Crotti, T., Holding, C., Weedon, H., Atkins, G., . . . Smith, M. (2003). Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. Rheumatology, 42(1), 123-134.
DOI Scopus136 WoS123 Europe PMC100
2003 Atkins, G., Kostakis, P., Pan, B., Farrugia, A., Gronthos, S., Evdokiou, A., . . . Zannettino, A. (2003). RANKL expression is related to the differentiation state of human osteoblasts. Journal of Bone and Mineral Research, 18(6), 1088-1098.
DOI Scopus221 WoS202 Europe PMC179
2003 Farrugia, A., Atkins, G., To, L., Pan, B., Horvath, N., Kostakis, P., . . . Zannettino, A. (2003). Receptor activator of nuclear factor-kB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo. Cancer Research, 63(17), 5438-5445.
Scopus203 WoS190 Europe PMC156
2003 Bouralexis, S., Findlay, D., Atkins, G., Labrinidis, A., Hay, S., & Evdokiou, A. (2003). Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy. British Journal of Cancer, 89(1), 206-214.
DOI Scopus62 WoS60 Europe PMC45
2003 Pan, B., To, L., Farrugia, A., Kostakis, P., Atkins, G., Findlay, D., & Zannettino, A. (2003). Multiple myeloma-derived pro-inflammatory cytokines enhance osteoclastogenesis by increasing the number of RANKL-expressing STRO-1 positive osteoprogenitor cells. Blood, 102(11), 5207.
2002 Atkins, G., Bouralexis, S., Evdokiou, A., Hay, S., Labrinidis, A., Zannettino, A., . . . Findlay, D. (2002). Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis. Bone, 31(4), 448-456.
DOI Scopus60 WoS60 Europe PMC48
2002 Findlay, D., Raggatt, L., Bouralexis, S., Hay, S., Atkins, G., & Evdokiou, A. (2002). Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanism. Journal of Endocrinology, 175(3), 715-725.
DOI Scopus20 WoS15 Europe PMC11
2002 Evdokiou, A., Bouralexis, S., Atkins, G., Chai, F., Hay, S., Clayer, M., & Findlay, D. (2002). Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to APO2L/TRIAL-induced apoptosis. International Journal of Cancer, 99(4), 491-504.
DOI Scopus132 WoS131 Europe PMC97
2002 Atkins, G., Haynes, D., Zannettino, A., Capone, M., Crotti, T., & Findlay, D. (2002). Haemopoietic cells influence stromal cell gene expression during human osteoclast development. Journal of Bone and Joint Surgery - British Volume, 84B(Suppl.3), 235.
2002 Atkins, G., Crotti, T., Loric, M., Findlay, D., Howie, D., Bain, G., & Haynes, D. (2002). Periprosthetic osteolysis is associated with wear particles stimulating factors that control osteoclast formation. Journal of Bone and Joint Surgery - British Volume, 84B(Suppl.3), 234.
2002 Atkins, G., Crotti, T., Loric, M., Findlay, D., Smith, M., & Haynes, D. (2002). Osteolysis in bone loss pathologies is associated with similar factors that control osteoclast formation. Asia Pacific Orthopaedic Association.. Journal of Bone and Joint Surgery - British Volume, 84B(Suppl.3), 234-235.
2001 Kuliwaba, J. S., Findlay, D. M., Atkins, G. J., Forwood, M. R., & Fazzalari, N. L. (2001). Gene expression in human cancellous bone is similar between skeletal sites.. JOURNAL OF BONE AND MINERAL RESEARCH, 16, S327.
2001 Zarrinkalam, K., Leavesley, D., Stanley, J., Atkins, G., & Faull, R. (2001). Expression of defensin antimicrobial peptides in the peritoneal cavity of patients on peritoneal dialysis. Peritoneal Dialysis International, 21(5), 501-508.
DOI Scopus15 WoS13 Europe PMC7
2001 Haynes, D., Crotti, T., Loric, M., Bain, G., Atkins, G., & Findlay, D. (2001). Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology, 40(6), 623-630.
DOI Scopus188 WoS168 Europe PMC138
2001 Haynes, D., Crotti, T., Potter, A., Loric, M., Atkins, G., Howie, D., & Findlay, D. (2001). The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. Journal of Bone and Joint Surgery-British Volume, 83B(6), 902-911.
DOI Scopus170 WoS142 Europe PMC108
2001 Fazzalari, N., Kuliwaba, J., Atkins, G., Forwood, M., & Findlay, D. (2001). The ratio of messenger RNA levels of receptor activator of nuclear factor kB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. Journal of Bone and Mineral Research, 16(6), 1015-1027.
DOI Scopus120 WoS104 Europe PMC92
2001 Evdokiou, A., Atkins, G., Bouralexis, S., Hay, S., Raggatt, L., Cowled, P., . . . Findlay, D. (2001). Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone. International Journal of Oncology, 19(3), 625-632.
DOI Scopus23 WoS22 Europe PMC18
2001 Atkins, G., Bouralexis, S., Haynes, D., Graves, S., Geary, S., Evdokiou, A., . . . Findlay, D. (2001). Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone. Bone, 28(4), 370-377.
DOI Scopus86 WoS83 Europe PMC68
2001 Fazzalari, N., Kuliwaba, J., Atkins, G., Forwood, M., & Findlay, D. (2001). Osteoclast differentiation factor is dominant in controlling the extent of bone resorption. Bone, 28(5), S160.
DOI
2001 Findlay, D., Bouralexis, S., Atkins, G., Chai, F., Hay, S., Clayer, M., & Evdokiou, A. (2001). Protection of normal human bone cells from Apo2L/TRAIL and chemotherapeutic drug combination-induced apoptosis. Bone, 28(5), S137.
DOI
2001 Atkins, G., Evdokiou, A., Bouralexis, S., Chai, F., Hay, S., Clayer, M., & Findlay, D. (2001). Chemotherapeutic drugs sensitise osteogenic sarcoma cells but not normal human bone cells to TRAIL-mediated apoptosis. Bone, 28(5), S82.
2001 Clayer, M., Bouralexis, S., Evdokiou, A., Hay, S., Atkins, G., & Findlay, D. (2001). Enhanced apoptosis of soft tissue sarcoma cells with chemotherapy: A potential new approach using TRAIL. Journal of Orthopaedic Surgery, 9(2), 19-22.
DOI Scopus18 Europe PMC15
2000 Atkins, G., Haynes, D., Graves, S., Evdokiou, A., Hay, S., Bouralexis, S., & Findlay, D. (2000). Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. Journal of Bone and Mineral Research, 15(4), 640-649.
DOI Scopus167 WoS167 Europe PMC131
2000 Kitahama, S., Gibson, M., Hatzinikolas, G., Hay, S., Kuliwaba, J., Evdokiou, A., . . . Findlay, D. (2000). Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cells. Bone, 27(1), 61-67.
DOI Scopus59 WoS57 Europe PMC45
2000 Findlay, D., Atkins, G., Forwood, M., Kuliwaba, J., & Fazzalari, N. (2000). Enhanced expression of osteocalcin mRNA in human osteoarthritic trabecular bone of the proximal femur is associated with decreased expression of interleukin-6 and interleukin-11 mRNA. Journal of Bone and Mineral Research, 15(2), 332-341.
DOI Scopus47 WoS44 Europe PMC38
2000 Atkins, G., Haynes, D., Geary, S., Loric, M., Crotti, T., & Findlay, D. (2000). Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation. Bone, 26(6), 653-661.
DOI Scopus69 WoS65 Europe PMC52
2000 Kuliwaba, J. S., Findlay, D. M., Atkins, G. J., Forwood, M. R., & Fazzalari, N. L. (2000). A molecular histomorphometric study of osteoarthritic cancellous bone. JOURNAL OF BONE AND MINERAL RESEARCH, 15(4), 811.
2000 Findlay, D. M., Bouralexis, S., Atkins, G. J., Hedi, L., Hay, S., & Evdokiou, A. (2000). TRAIL-induced apoptosis of osteogenic sarcoma and breast cancer cells.. JOURNAL OF BONE AND MINERAL RESEARCH, 15, S352.
1999 Atkins, G. J., Haynes, D. R., Graves, S. E., Evdokiou, A., Hay, S., Bouralexis, S., . . . Findlay, D. M. (1999). Expression of osteoclast differentiation signals by stromal elements of giant cell tumours.. JOURNAL OF BONE AND MINERAL RESEARCH, 14, S176.
WoS1
1999 Evdokiou, A., Atkins, G. J., Bouralexis, S., Hay, S. J., Raggatt, L. J., & Graves, S. E. (1999). Differential expression of MDM2 splice variants in bone tumors. MOLECULAR BIOLOGY OF THE CELL, 10, 428A.
1999 Kuliwaba, J. S., Findlay, D. M., Atkins, G. J., Forwood, M. R., & Fazzalari, N. L. (1999). Bone remodelling in osteoarthritic cancellous bone a molecular histomorphometric study.. JOURNAL OF BONE AND MINERAL RESEARCH, 14, S464.
1999 Evdokiou, A., Raggatt, L., Findlay, D., & Atkins, G. (1999). Calcitonin Receptor-Mediated Growth Suppression of HEK-293 Cells is Accompanied by Induction of p21 WAF1/CIP1 and G2/M Arrest. Molecular Endocrinology, 13(10), 1738-1750.
DOI Scopus38 WoS34 Europe PMC23
1999 Haynes, D., Atkins, G., Loric, M., Crotti, T., Geary, S., & Findlay, D. (1999). Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation. Bone, 25(3), 269-278.
DOI Scopus40 WoS34 Europe PMC28
1998 Evdokiou, A., Raggatt, L., Atkins, G. J., & Findlay, D. M. (1998). Growth inhibition by calcitonin of HEK293 cells is accompanied by induction of p21/WAF1/CIP1 and G2/M arrest. MOLECULAR BIOLOGY OF THE CELL, 9, 484A.
1997 Atkins, G., Qiao, M., Coombe, D., Gowans, E., & Ashman, L. (1997). Hepatitis B virus binding to leucocyte plasma membranes utilizes a different region of the preS1 domain to the hepatocyte receptor binding site and does not require receptors for opsonins.. Immunology and Cell Biology, 75(3), 259-266.
DOI Scopus3 WoS1
- Findlay, D. M., & Atkins, G. J. (2012). Mammals and minerals: a story of lactation and lacunae. IBMS BoneKEy, 9.
DOI

Year Citation
2018 Anderson, P., Atkins, G., Morris, H., & Findlay, D. (2018). Vitamin D Activities in Osteocytes. In D. Feldman, J. W. Pike, R. Bouillon, E. Giovannucci, D. Goltzman, & M. Hewison (Eds.), Vitamin D: Fourth Edition (Vol. 1, 4th ed., pp. 319-327). London, United Kingdom: Academic Press.
DOI Scopus1
2015 Gulati, K., Kogawa, M., Maher, S., Atkins, G., Findlay, D., & Losic, D. (2015). Titania nanotubes for local drug delivery from implant surfaces. In D. Losic, & A. Santos (Eds.), Electrochemically Engineered Nanoporous Materials: Methods, Properties and Applications (Vol. 220, pp. 307-355). Switzerland: Springer.
DOI Scopus45
2011 Atkins, G., Findlay, D., Anderson, P., & Morris, H. (2011). Target genes: Bone proteins. In D. Feldman, J. Pike, & J. Adams (Eds.), Vitamin D (Vol. 1, 3rd ed., pp. 411-424). Elsevier.
DOI Scopus26
2011 Findlay, D., & Atkins, G. (2011). TWEAK and TNF regulation of sclerostin: a novel pathway for the regulation of bone remodelling. In D. Wallach, A. Kovalenko, & M. Feldmann (Eds.), Advances in TNF Family Research (Vol. 691, 1 ed., pp. 337-348). 233 Spring St New York NY 10013: Springer.
DOI Scopus15 WoS12 Europe PMC12
2011 Atkins, G. J., Findlay, D. M., Anderson, P. H., & Morris, H. A. (2011). Target Genes: Bone proteins. In Vitamin D Two Volume Set (Vol. 1-2, pp. 411-424).
DOI
2005 Zannettino, A., Farrugia, A., To, L., & Atkins, G. (2005). An in vitro osteoclast-forming assay to measure myeloma cell-derived osteoclast-activating factors. In R. Brown, & P. Joy Ho (Eds.), Multiple Myeloma: Methods and Protocols (Vol. 113, pp. 245-256). Totowa, New Jersey: Humana Press.
DOI Scopus3 Europe PMC1
2004 Atkins, G., Findlay, D., Anderson, P., & Morris, H. (2004). Target genes: bone proteins. In D. Feldman, J. Pike, & F. Glorieux (Eds.), Vitamin D, 2nd. ed (Vol. 1, 2nd ed., pp. 711-720). San Diego, California: Elsevier Academic Press.
DOI Scopus4
2004 Atkins, G. J., Findlay, D. M., Anderson, P. H., & Morris, H. A. (2004). Target Genes: Bone Proteins. In Vitamin D Second Edition (pp. 711-720).
DOI

Year Citation
2021 Bennett, K., Rapagna, S., Wearne, L., Martelli, S., Atkins, G., Solomon, B., . . . Thewlis, D. (2021). Preliminary Micro-CT Imaging of the Human Tibial Plateau Under Load. In XXVIII Congress of the International Society of Biomechanics (ISB). Stockholm, Sweden.
2019 Grace, T. M., O'Rourke, D., Atkins, G., Taylor, M., Solomon, B., & Thewlis, D. (2019). The Development and Reliability of a Semi-Automated Method to Split the Acetabulum into Clinically Relevant Regions of Interest. In ANZORS 25th Annual Scientific Meeting. Canberra.
2019 Grace, T., Atkins, G., Taylor, M., Solomon, B., & Thewlis, D. (2019). The Feasibility of a Workflow for Investigating Peri-Prosthetic Osteolysis. In AOA SA/NT Branch Scientific Meeting. Adelaide.
2018 Sharma, D. K., Stamenkov, R., Robertson, T., Stapledon, C. J. M., Atkins, G. J., Solomon, L. B., . . . Morris, H. A. (2018). SERUM 25-HYDROXYVITAMIN D AND ITS METABOLISM IN BONE TISSUE IS ASSOCIATED WITH IMPROVED BONE QUALITY IN ELDERLY HIP PATIENTS. In OSTEOPOROSIS INTERNATIONAL Vol. 29 (pp. S271). Krakow, POLAND: SPRINGER LONDON LTD.
2018 Noonan, M. L., Clinkenbeard, E. L., Ni, P., Ivan, M., Prideaux, M., Atkins, G. J., . . . White, K. E. (2018). Directly targeting HIF activity controls FGF23 expression and has implications for translational outcomes. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 33 (pp. 355). Montreal, CANADA: WILEY.
2017 Liapis, V., Labrinidis, A., Zinonos, I., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2017). Hypoxia-activated pro-drug Evofosfamide exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma. In CLINICAL & EXPERIMENTAL METASTASIS Vol. 34 (pp. 222-223). SPRINGER.
2017 Liapis, V., Zinonos, I., Labrinidis, A., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2017). Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models. In CLINICAL & EXPERIMENTAL METASTASIS Vol. 34 (pp. 222). SPRINGER.
2016 Makar, S., Qin, J., Gulati, K., ElMekawy, A., Kaur, G., Lima-Marques, L., . . . Losic, D. (2016). 3D printed titanium implants with nano-engineered surface titania nanotubes for localized drug delivery. In Chemeca 2016 (pp. 1-12). online: Engineers Australia.
2014 Mokhtarzadeh, H., Aw, M., Khalid, K., Gulati, K., Atkins, G., Findlay, D., . . . Pivonka, P. (2014). Computational and experimental model of nano-engineered drug delivery system for trabecular bone. In E. Onate, X. Oliver, & A. Huerta (Eds.), 11th World Congress on Computational Mechanics, WCCM 2014, 5th European Conference on Computational Mechanics, ECCM 2014 and 6th European Conference on Computational Fluid Dynamics, ECFD 2014 (pp. 868-879). Barcelona, Spain: International Center for Numerical Methods in Engineering.
Scopus1
2013 Gulati, K., Atkins, G., Findlay, D., & Losic, D. (2013). Nano-engineered titanium for enhanced bone therapy. In Proceedings of the SPIE 2013 Optics & Photonics Conference Vol. 8812 (pp. 1-6). Online: SPIE-International Society for Optical Engineering.
DOI Scopus26 WoS23
2012 Aw, M., Gulati, K., Atkins, G., Findlay, D., & Losic, D. (2012). Controlling drug release from titania nanotube arrays using polymer nanocarriers and biopolymer coating. In Proceedings of the 10th Asia-Pacific Microscopy Conference, APMC10, the International Conference on Nanoscience & Nanotechnology, ICONN2012 and the 22nd Australian Conference on Microscopy & Microanalysis, ACMM22 (pp. 655-1-655-2). Perth.
2011 Wijenayaka, A. R., Kogawa, M., Lim, H. P., Bonewald, L. F., Findlay, D. M., & Atkins, G. J. (2011). SCLEROSTIN INDUCES OSTEOCYTE SUPPORT OF OSTEOCLAST FORMATION AND OSTEOCLAST ACTIVITY. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S550). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2011 Atkins, G. J., Vincent, C., Wijenayaka, A. R., Welldon, K. J., Haynes, D. R., Zheng, T. S., . . . Findlay, D. M. (2011). THE EFFECTS OF TWEAK AND TNF ON HUMAN OSTEOBLASTS: MAPK DEPENDENT INDUCTION OF SCLEROSTIN EXPRESSION. In D. Wallach, A. Kovalenko, & M. Feldman (Eds.), ADVANCES IN TNF FAMILY RESEARCH Vol. 691 (pp. 688). San Lorenzo del Escorial, SPAIN: SPRINGER-VERLAG BERLIN.
2011 Welldon, K. J., Findlay, D. M., & Atkins, G. J. (2011). CALCIUM AS AN ANABOLIC STIMULUS OF OSTEOBLAST DIFFERENTIATION TO AN OSTEOCYTE-LIKE PHENOTYPE. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S611). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2011 Evdokiou, A., Liapis, V., Hay, S., Keramidas, A., Maltezou, E., Christou, Y., . . . Odysseos, A. (2011). The vitamin E analogue Γ-tocotrienol blocks osteoclastogenesis and promotes osteogenesis: Evidence for combined anti-osteolytic and bone forming activity. In BONE Vol. 48 (pp. S106). Athens, GREECE: ELSEVIER SCIENCE INC.
DOI
2011 Findlay, D., & Atkins, G. J. (2011). OSTEOCYTES AND CALCIUM: A LITTLE BIT OF GIVE AND TAKE. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S513). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2011 Yang, D., Atkins, G. J., Anderson, P. H., Welldon, K. J., & Morris, H. A. (2011). THE ROLE OF VITAMIN D IN THE PROLIFERATION AND DIFFERENTIATION OF OSTEOBLASTS IN VITRO. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S592). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2011 Turner, A. G., O'loughlin, P. D., Kogawa, M., Atkins, G. J., Anderson, P. H., & Morris, H. A. (2011). INCREASED BONE VOLUME IN THE BONE-SPECIFIC CYP27B1 TRANSGENIC MOUSE. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S590-S591). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
WoS5
2011 Kogawa, M., Findlay, D. M., Anderson, P. H., Morris, H. A., & Atkins, G. J. (2011). 25(OH)-VITAMIN D3 ACTS DIRECTLY ON OSTEOCLASTS TO REDUCE RESORPTION: WHAT IS THE MECHANISM?. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S586). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2011 Khalid, K. A., Ormsby, R. T., Welldon, K. J., Lim, H. P., Syazwani, S., FatinNabilah, S., . . . Findlay, D. M. (2011). RESPONSE TO LOADING IN EX VIVO BOVINE BONE. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S570). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2009 Welldon, K. J., Holding, C., Haynes, D. R., Howie, D. W., Findlay, D. M., & Atkins, G. J. (2009). Polyethylene particles activate pro-osteoclastogenic signalling pathways in human primary osteoblasts and osteocytes. In BONE Vol. 44 (pp. S127-S128). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI
2009 Kogawa, M., Findlay, D. M., Anderson, P. H., Vincent, C., & Atkins, G. J. (2009). The metabolism of 25(OH)-vitamin D<sub>3</sub> by osteoclast precursors regulates the differentiation and function of osteoclasts. In BONE Vol. 44 (pp. S60-S61). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI
2009 Atkins, G. J., Vincent, C., Wijenayaka, A. R., Welldon, K. J., & Findlay, D. M. (2009). TNF-related weak inducer of apoptosis (TWEAK) and sclerostin both signal via Erk-1/2 phosphorylation in human osteoblasts. In BONE Vol. 44 (pp. S56-S57). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI
2009 Wijenayaka, A. R., Vincent, C., Findlay, D. M., Welldon, K. J., Zheng, T. S., Haynes, D. R., . . . Atkins, G. J. (2009). The proinflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFa induce the mitogen activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. In BONE Vol. 44 (pp. S63). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI WoS1
2008 Anderson, P. H., Atkins, G. J., Sawyer, R. K., Findlay, D. M., O'Loughlin, P. D., & Morris, H. A. (2008). The Requirement of the Bone for Vitamin D for 1,25(OH)<sub>2</sub>D<sub>3</sub> Synthesis and Bone Mineralisation.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 23 (pp. S429). Montreal, CANADA: WILEY-BLACKWELL.
WoS1
2008 Atkins, G. J., Vincent, C., Wijenayaka, A. R., Welldon, K. J., Haynes, D. R., Zheng, T. S., . . . Findlay, D. M. (2008). The Proinflammatory Cytokine TWEAK Induces Sclerostin Expression in Human Immature Osteoblasts in a MAPK Dependent Fashion.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 23 (pp. S385). Montreal, CANADA: AMER SOC BONE & MINERAL RES.
2007 Atkins, G. J., Vincent, C., Welldon, K. J., Haynes, D. R., Holding, C., Zheng, T. S., . . . Findlay, D. M. (2007). TWEAK is a regulator of human osteoblast function. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 22 (pp. S138). Honolulu, HI: AMER SOC BONE & MINERAL RES.
2006 Atkins, G. J., Welldon, K. J., Vincent, C., & Findlay, D. M. (2006). Vitamin K analogues promote the differentiation of primary human osteoblasts.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 21 (pp. S155). Philadelphia, PA: AMER SOC BONE & MINERAL RES.
2006 Welldon, K., Atkins, G., Vincent, C., & Findlay, D. (2006). Vitamin K analogues promote the differentiation of human osteoblasts.. In Journal of Bone Mineral Research Vol. 21 (pp. SA-204.). Philadelphia, Pennsylvania: American Society for Bone and Mineral Research.
2006 Zarrinkalam, M. R., Nattrass, G., Beard, H., Atkins, G. J., Findlay, D. M., & Moore, R. J. (2006). Mechanisms of trabecular bone loss in an ovine model of osteoporosis. In OSTEOPOROSIS INTERNATIONAL Vol. 17 (pp. S324). Washington, DC: SPRINGER LONDON LTD.
2005 Kostakis, P., Atkins, G., Vincent, C., Farrugia, A., Findlay, D., Evdokiou, A., & Zannettino, A. (2005). RANK expression in normal and malignant cells: a monoclonal antibody study. In Journal of Bone and Mineral Research Vol. 20 (pp. SA-259.). Nashville, Tennessee: American Society for Bone and Mineral Research.
2005 Bouralexis, S., Findlay, D. M., Atkins, G. J., Hay, S., & Evdokiou, A. (2005). Chemotherapy sensitises osteogenic sarcoma cells but not normal cells to trail-induced apoptosis. In CANCER TREATMENT REVIEWS Vol. 31 (pp. S33-S34). Davos, SWITZERLAND: W B SAUNDERS CO LTD.
2005 Atkins, G. J., Kostakis, P., Vincent, C., Farrugia, A. N., Findlay, D. M., Evdokiou, A., & Zannettino, A. C. W. (2005). RANK expression in normal and malignant haemopoietic cells: A monoclonal antibody study.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 20 (pp. S146). Nashville, TN: AMER SOC BONE & MINERAL RES.
2004 Atkins, G. J., Anderson, P. H., Welldon, K., Zannettino, A. C. W., Morris, H. A., & Findlay, D. M. (2004). Vitamin D metabolism in human osteoblasts.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 19 (pp. S204). Seattle, WA: AMER SOC BONE & MINERAL RES.
2004 Atkins, G., Anderson, P., Welldon, K., Zannettino, A., Morris, H., & Findlay, D. (2004). Vitamin D metabolism in human osteoblasts. In Journal of Bone and Mineral Research Vol. 19 (pp. SA-587). Seattle, Washington: American Society for Bone and Mineral Research.
2003 Kostakis, P., Atkins, G., Pan, B., Farrugia, A., Gronthos, S., Evdokiou, A., . . . Zannettino, A. (2003). The relationship between RANKL expression and osteoblast differentiation in human osteoblasts. In 30th European Symposium on Calcified Tissues, 8-12 May 2003 Vol. Italy (pp. 314-468). Rome, Italy: Springer Science and Business Media LLC.
DOI
2003 Atkins, G. J., Anderson, P. H., Morris, H. A., Zannettino, A. C. W., Kostakis, P., & Findlay, D. M. (2003). The expression of 25-hydroxyvitamin D 24-hydroxylase and 25-hydroxyvitamin D 1 alpha-hydroxylase in human osteoblasts.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 18 (pp. S409). MINNEAPOLIS, MINNESOTA: AMER SOC BONE & MINERAL RES.
2003 Dassios, H., Findlay, D. M., Kuliwaba, J. S., Atkins, G. J., & Fazzalari, N. L. (2003). Enhanced gene expression of osteoclastogenic factors in human osteoporotic trabecular bone. In BONE Vol. 32 (pp. S149). OSAKA, JAPAN: ELSEVIER SCIENCE INC.
2003 Pan, B. Q., To, L. B., Farrugia, A. N., Kostakis, P., Atkins, G. J., Findlay, D. M., & Zannettino, A. C. W. (2003). Multiple myeloma-derived pro-inflammatory cytokines enhance osteoclastogenesis by increasing the number of RANKL-expressing STRO-1 positive osteoprogenitor cells.. In BLOOD Vol. 102 (pp. 370B). SAN DIEGO, CALIFORNIA: AMER SOC HEMATOLOGY.
2002 Atkins, G., Zannettino, A., Kostakis, P., Pan, B., Farrugia, A., Evdokiou, A., & Findlay, D. (2002). Evidence for the maturation-dependent expression of an osteoclastogenic phenotype in human osteoblasts.. In Journal of Bone and Mineral Research Vol. 17 (pp. S446.). San Antonio, Texas: American Society for Bone and Mineral Research.
2002 Atkins, G., Pan, B., Findlay, D., To, L., Evdokiou, A., Labrinidis, A., . . . Zannettino, A. (2002). Zoledronate is anabolic for human osteoblast-like cells. In Journal of Bone and Mineral Research Vol. 17 (pp. S442.). San Antonio, Texas: American Society for Bone and Mineral Research.
2001 Atkins, G., Kuliwaba, J., Findlay, D., Forwood, M., & Fazzalari, N. (2001). Differential Gene Expression in the Human Bone Microenvironment of the Hip; Comparison Between Control and Osteoarthritis.. In Journal of Bone and Joint Surgery (Br.) Vol. 84-B (pp. 235). Adelaide, South Australia: The British Editorial Society of Bone and Joint Surgery.
1999 Atkins, G. J., Loric, M., Crotti, T. N., Haynes, D. R., & Findlay, D. M. (1999). Osteoclast differentiation factors are expressed by both stromal and haematopoietic cells in human osteoclast formation. In H. Stein, S. I. Suk, P. C. Leung, K. G. Thorngren, & W. Akeson (Eds.), SIROT 99 (pp. 547-551). SYDNEY, AUSTRALIA: FREUND PUBL HOUSE LTD.
1999 Crotti, T. N., Potter, A. E., Atkins, G. J., Findlay, D. M., Howie, D. W., & Haynes, D. R. (1999). Osteoclast differentiation and development is regulated by mediators released in response to prosthetic particles. In H. Stein, S. I. Suk, P. C. Leung, K. G. Thorngren, & W. Akeson (Eds.), SIROT 99 (pp. 542-546). AUSTRALIA, SYDNEY: FREUND PUBL HOUSE LTD.
1999 Kuliwaba, J. S., Findlay, D. M., Atkins, G. J., Forwood, M. R., & Fazzalari, N. L. (1999). Gene expression in osteoarthritic cancellous bone is consistent with osteoarthritis being a disease of the skeleton. In H. Stein, S. I. Suk, P. C. Leung, K. G. Thorngren, & W. Akeson (Eds.), SIROT 99 (pp. 437-441). SYDNEY, AUSTRALIA: FREUND PUBL HOUSE LTD.

Year Citation
2021 Bennett, K., Pizzolato, C., Martelli, S., Bahl, J., Sivakumar, A., Atkins, G., . . . Thewlis, D. (2021). Estimations of Knee Joint Loading Using Generalized Methods and Muscle Recruitment Strategies. Poster session presented at the meeting of XXVIII Congress of the International Society of Biomechanics (ISB).
2021 Muratovic, D., Findlay, D. M., Masri, H. H., Stapledon, C. J., Lee, Y., Cao, X., . . . Kuliwaba, J. S. (2021). ELEVATED LEVELS OF ACTIVE TRANSFORMING GROWTH FACTOR beta 1 IN THE SUBCHONDRAL BONE RELATE SPATIALLY TO IMPAIRED BONE QUALITY AND CARTILAGE LOSS IN HUMAN KNEE OSTEOARTHRITIS. Poster session presented at the meeting of OSTEOARTHRITIS AND CARTILAGE. ELSEVIER SCI LTD.
DOI
2019 Bennett, K. J., Millar, S., Fraysse, F., Arnold, J., Atkins, G., Solomon, L., . . . Thewlis, D. (2019). Longitudinal Postoperative Joint Kinematics of Tibial Plateau Fracture Patients. Poster session presented at the meeting of ANZORS 25th Annual Scientific Meeting. Canberra, ACT, Australia.
2017 Liapis, V., Labrinidis, A., Zinonos, I., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2017). Anticancer efficacy of the hypoxia-activated pro-drug evofosfamide in prcelinIcal osteosarcoma murine models. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. SPANDIDOS PUBL LTD.
2017 Liapis, V., Zinonos, I., Labrinidis, A., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2017). The hypoxia activated pro-drug evofosfamide exhibits tumour suppressive activity and synergy with chemotherapy against primary and metastatic breast cancers. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. SPANDIDOS PUBL LTD.
2003 Atkins, G., Anderson, P., Morris, H., Zannettino, A., Kostakis, P., & Findlay, D. (2003). The expression of 25-hydroxyvitaminD 24-hydroxylase and 25-hydroxyvitaminD 1 alpha-hydroxylase in human osteoblasts. Poster session presented at the meeting of Journal of Bone Mineral Research. Minnesota, USA.
2003 Anderson, P., Atkins, G., Morris, H., Kostakis, P., Findlay, D., & Zannettino, A. (2003). The expression of 25-hydroxyvitaminD 24-hydroxylase and 25-hydroxyvitaminD 1 alpha-hydroxylase in human osteoblasts.. Poster session presented at the meeting of Calcified Tissue International. Rome, Italy: Springer.

Year Citation
2020 Solomon, L. B., Atkins, G., Freeman, B., Howie, D., Findlay, D., Smitham, P., . . . Jones, C. (2020). COTR publications [website]. University of Adelaide: Dan McCafferty.

Year Citation
2025 Gunn, N., Zelmer, A., Kidd, S., Solomon, B., Carda-Diéguez, M., Mira, A., . . . Atkins, G. (2025). Chronic <i>Staphylococcus aureus</i> infection of osteocytes promotes an intracellular viable-but-non-culturable phenotype.
DOI
2025 Kitchen, D., Ricci, S., Abrahams, J., Downie, M., Atkins, G., Solomon, L., & Smitham, P. (2025). Patients Report Better Outcomes Following Reduction of Tibial Plateau Fractures: A Systematic Review.
DOI
2025 Dharmapatni, A. A. S. S. K., Crotti, T. N., Ormsby, R. T., Kogawa, M., Solomon, L. B., Findlay, D. M., . . . Atkins, G. J. (2025). TWEAK and Fn14 expression in osteoarthritis: evidence for TWEAK-induced RANKL release from chondrocytes.
DOI
2024 Sun, Q., Huynh, K., Muratovic, D., Gunn, N. J., Zelmer, A. R., Solomon, L. B., . . . Yang, D. (2024). Beyond the Colony-Forming-Unit: Rapid Bacterial Evaluation in Osteomyelitis.
DOI Scopus1 Europe PMC4
2023 Zelmer, A., Yang, D., Gunn, N., Solomon, B., Nelson, R., Kidd, S., . . . Atkins, G. (2023). Antibiotics at Clinical Concentrations Show Limited Effectivity Against Acute and Chronic Intracellular<i>S. aureus</i>Infections in Osteocytes.
DOI
2021 Hofstaetter, J., Atkins, G., Kogawa, M., Blouin, S., Misof, B., Roschger, P., . . . Ito, N. (2021). A case of autosomal dominant osteopetrosis type II with a severe bone phenotype but no amino acid converting mutation in the <i>CLCN7</i> gene.
DOI
2021 Kitchen, D., Richards, J., Smitham, P., Atkins, G., & Solomon, L. (2021). Does Time to Theatre Affect The Ability to Achieve Fracture Reduction in Tibial Plateau Fractures?.
DOI

Date Role Research Topic Program Degree Type Student Load Student Name
2024 Principal Supervisor Utility of nucleic acid sequencing for improving diagnosis of periprosthetic joint infection Doctor of Philosophy Doctorate Full Time Ms Kimberley Huynh
2024 Principal Supervisor Utility of nucleic acid sequencing for improving diagnosis of periprosthetic joint infection Doctor of Philosophy Doctorate Full Time Ms Kimberley Huynh
2022 Principal Supervisor Understanding the Role of Gut Microbiome in Prosthetic Joint Infections. Doctor of Philosophy Doctorate Part Time APrf Boopalan Ramasamy
2022 Co-Supervisor Risk factors for re-infection in two-staged total hip replacement revision Master of Philosophy (Surgery) Master Part Time Mr Ameya Bhanushali
2022 Principal Supervisor Pathologic bone matrix destruction: help or hindrance for the diagnosis and treatment of chronic osteomyelitis and osteosarcoma? Doctor of Philosophy Doctorate Full Time Mr Qi Sun
2022 Principal Supervisor The Host Osteocyte Response to Bacterial Infection in Osteomyelitis Doctor of Philosophy Doctorate Full Time Mr Mohammad Amjad Hossain
2022 Principal Supervisor The Host Osteocyte Response to Bacterial Infection in Osteomyelitis Doctor of Philosophy Doctorate Full Time Mr Mohammad Amjad Hossain
2022 Principal Supervisor Understanding the Role of Gut Microbiome in Prosthetic Joint Infections. Doctor of Philosophy Doctorate Full Time APrf Boopalan Ramasamy
2022 Co-Supervisor Risk factors for re-infection in two-staged total hip replacement revision Master of Research Master Full Time Mr Ameya Bhanushali
2022 Principal Supervisor Pathologic bone matrix destruction: help or hindrance for the diagnosis and treatment of chronic osteomyelitis and osteosarcoma? Doctor of Philosophy Doctorate Full Time Mr Qi Sun

Date Role Research Topic Program Degree Type Student Load Student Name
2021 - 2025 Principal Supervisor The Effect of Time on the Surgical Management of Tibial Plateau Fractures Doctor of Philosophy Doctorate Part Time Dr David Stuart Kitchen
2020 - 2024 Principal Supervisor Mechanisms of Persistence, Reactivation and Eradication of Staphylococci in Orthopaedic Infections Doctor of Philosophy Doctorate Full Time Ms Anja Ruth Zelmer
2019 - 2022 Co-Supervisor In Silico, Ex Vivo, and In Vivo approaches for Modelling Tibial Plateau Fractures Doctor of Philosophy Doctorate Part Time Dr Kieran James Bennett
2018 - 2022 Co-Supervisor Engineering Novel Nano-Structured 3D-Printed Titanium Implants for Optimized Osseointegration, Antibacterial Protection and Localized Drug Delivery Applications Doctor of Philosophy Doctorate Full Time Mr Shaheer Guirguis Maher Makar
2017 - 2022 Co-Supervisor Investigating the biomechanics and genetics of acetabular peri-prosthetic osteolysis Doctor of Philosophy Doctorate Full Time Mr Thomas Michael Grace
2017 - 2025 Principal Supervisor An Investigation into the Mechanisms of Persistence Utilised by Intra-Osteocytic Staphylococcus aureus Doctor of Philosophy Doctorate Full Time Mr Nicholas James Gunn
2016 - 2019 Principal Supervisor The Role of the Osteocyte in Periprosthetic Osteolysis Doctor of Philosophy Doctorate Full Time Ms Renee Ormsby
2016 - 2020 Principal Supervisor A Novel Investigation into the Role of Neurotrophic Factors in the Osteocyte and Bone Doctor of Philosophy Doctorate Full Time Miss Catherine Stapledon
2012 - 2020 Principal Supervisor The Role of Vitamin D Autocrine Activity and Signalling in Osteoclast Formation and Activity Doctor of Philosophy Doctorate Full Time Daniel Christopher Reinke
2011 - 2012 Principal Supervisor The Effect of Bone Anabolic Stimuli on Human Osteoblast to Osteocyte Transition Master of Philosophy (Medical Science) Master Full Time Ms Katie Welldon
2010 - 2014 Principal Supervisor The regulation of the sclerostin gene and the catabolic effects of sclerostin protein on bone Doctor of Philosophy Doctorate Full Time Dr Asiri Wijenayaka
2009 - 2015 Co-Supervisor The Interaction between Vitamin D and Extracellular Calcium on Osteogenic Differentiation Doctor of Philosophy Doctorate Full Time Dr Dongqing Yang
2009 - 2019 Principal Supervisor Ex Vivo Bone Culture: A Novel Method for Investigating Mechanical Loading Response and Osteocytes in Situ In Trabecular Bone Doctor of Philosophy Doctorate Full Time Dr Kamarul Ariffin Khalid
2006 - 2012 Principal Supervisor The Underlying Molecular Regulators and their Effects on Mineralisation in the Trabecular Bone Microenvironment and Osteoblast of Primary Hip Osteoarthritis Doctor of Philosophy Doctorate Full Time Mr Duminda Danajaya Kumarasinghe
2000 - 2003 Co-Supervisor Molecular Mechanisms of Apo2L/TRAIL Induced Apoptosis In Normal and Malignant Cells Doctor of Philosophy Doctorate Full Time Mr Stelios Bouralexis

Connect With Me

External Profiles

Other Links